Transcript for Woman who experienced blood clots after taking J&J vaccine in recovery
Now to the coronavirus emergency with the CDC set to meet on the Johnson & Johnson vaccine pause, we are now learning the identity of one of the six women battling those rare blood clots, an 18-year-old from Nevada and whit Johnson has the latest on all of that. Good morning, whit. Reporter: Amy, good morning, the Johnson & Johnson vaccine is still on hold here in the U.S. While health experts investigate those rare cases of blood clots in at least six women and now we're hearing from the family of an 18-year-old who says her reaction was so severe she was hospitalized and placed in a medically induced coma. This morning, as the CDC advisory panel prepares to meet to discuss the Johnson & Johnson vaccine, this 18-year-old is fighting for her life, according to a family spokesperson, Emmy Burkey from Nevada is one of the signature women experiencing those rare blood clots. The family is very concerned. You know, it's just one of those situations, you know, where are we going to be able to keep her, are we going to lose her. Reporter: A spokesperson for the family says she suffered multiple seizures a few days after getting her shot, was hospitalized and placed in a medically induced coma. Now she is slowly recovering. The rare blood clots reported in only six of the nearly 7 million Americans who have received the one-dose vaccine. A less than 1 in a million occurrence. While it's unclear if the vaccine is responsible for the clots, regulators paused the use of the Johnson & Johnson vaccine last week while they investigate. Despite Burkey's illness her parents still advocating for people to get vaccinated. They are 100% in favor of people getting vaccinated, in fact, both of them have been and they see this as just a, you know, a one in a million situation. Eporter: Now, European regulators determined that the benefits of the Johnson & Johnson vaccine outweighed the risks and yesterday made the call, the recommendation that the shots should move forward as long as it comes with a warning about the possible link between the vaccine and those rare blood clot, meanwhile, here in the U.S., the CDC advisory panel is expected to meet again on Friday to discuss the vaccine and possibly make a recommendation,
This transcript has been automatically generated and may not be 100% accurate.